Expression patterns of epithelial differentiation antigens and lectin-binding sites in ameloblastomas: a comparison with basal cell carcinomas.
Whether the peripheral ameloblastoma (PA) and intraoral basal cell carcinoma (BCC) are two different clinical entities or essentially the same lesion still remains unresolved. The immunophenotypes of neoplastic cells of peripheral and intraosseous ameloblastomas, ameloblastic carcinomas, and BCCs were studied using a panel of monoclonal/polyclonal antibodies and lectins. The major cytokeratins (CKs) of neoplastic cells of ameloblastomas were CKs 5 and 14, whereas co-expression of CKs 8, 18, and 19 was observed in the cells of the stellate reticulum-like areas. Metaplastic squamous and keratinizing cells found in follicular and acanthomatous variants of ameloblastomas expressed CKs 1 and 10, involucrin, and binding sites for the lectins Ulex europeaus agglutinin I and Helix pomatia agglutinin. beta 2-Microglobulin was uniformly negative in all cases of ameloblastomas and ameloblastic carcinomas studied. Cutaneous BCCs also demonstrated similar reactive patterns with the above-mentioned antigens. The most striking feature is the presence of a peritumorous band-like peanut agglutinin staining found in both BCCs and PAs but not in intraosseous ameloblastomas. This unique peanut agglutinin staining pattern of PA may be diagnostically useful for its histopathologic distinction from an intraosseous ameloblastoma that has infiltrated the soft tissue. The neoplastic cells of ameloblastomas express markers of less-differentiated epithelial cells. Despite differences in epithelial origins, PAs are tumors analogous to cutaneous BCCs.
Vigneswaran
N
N
Department of Oral Pathology, School of Dentistry, UAB 35294-0007.
Whitaker
S B
SB
Budnick
S D
SD
Waldron
C A
CA
D000293:Adolescent; D000328:Adult; D000368:Aged; D000564:Ameloblastoma / Q000276:immunology* / Q000473:pathology*; D000943:Antigens, Differentiation / Q000032:analysis*; D001859:Bone Neoplasms / Q000276:immunology / Q000473:pathology; D002280:Basal Cell Carcinoma / Q000276:immunology* / Q000473:pathology*; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D007633:Keratins / Q000032:analysis; D037102:Lectins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D011498:Protein Precursors / Q000032:analysis; D011975:Receptors, Mitogen / Q000032:analysis; D012878:Skin Neoplasms / Q000276:immunology / Q000473:pathology; D012983:Soft Tissue Neoplasms / Q000276:immunology / Q000473:pathology; D001613:beta 2-Microglobulin / Q000032:analysis
D000943:Antigens, Differentiation; D037102:Lectins; D011498:Protein Precursors; D011975:Receptors, Mitogen; D001613:beta 2-Microglobulin; C032253:involucrin; D007633:Keratins